Program Description:
Psychedelics, including Psilocybin (a compound found in so-called ‘magic mushrooms’), have shown promise in treating a range of addictions and mental health disorders. This intermediate-level interactive webinar lecture will cover the historical context of psychedelic use, including their traditional use in indigenous cultures and their resurgence in modern research. It will also present empirical evidence for the therapeutic utility of psychedelics in treating depression and smoking cessation.
Participants will learn about the delivery of psychedelic-assisted psychotherapy, including the nature of psychedelic therapy as a form of psychotherapy, relevant cases, and future clinical considerations. However, this training does not cover use of ketamine.
Clinical Objectives:
- Discuss the historical context of psychedelic use
- Review the empirical evidence of therapeutic utility of psychedelics for depression and smoking cessation
- Describe how psychedelic assisted psychotherapy is delivered
- Describe the nature of psychedelic therapy as psychotherapy
- Identify relevant cases for use of psychedelics
- Discuss future clinical considerations for use of psychedelics
Event Details:
CE Information:
- 3 CEs for psychologists (all states)
- 3 CEs for Social Workers – New York, Virginia & Washington DC
Cost:
- Individual with CE credit: $75
- Student/Non-CE participant: $50
- Free for ADAA members. The Ross Center, in collaboration with ARC Health, is pleased to provide ADAA members access to continuing education opportunities at no cost.
Registration:
Presented by: Sandeep Navak, MD
Sandeep Nayak, MD: Dr. Nayak is an Assistant Professor at Johns Hopkins Center for Psychedelic and Consciousness Research, which focuses on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. He completed his MD at Brown University and his psychiatry residency at Johns Hopkins Hospital. He’s primarily focused on investigating psychedelics as treatments for psychiatric conditions, particularly substance use disorders and mood disorders. His other research interests within the field include the application of Bayesian statistics to clinical trials and psychedelic induced belief changes. Dr. Nayak also works as a psychiatrist at Addiction Treatment Services (ATS) and The Center for Addiction and Pregnancy (CAP) at Johns Hopkins Bayview Medical Center.
Agenda: Click here to view
Testimonials:
“Dr Nayak was engaging throughout the entire presentation and made the 3hrs fly by. 10 out of 10.”
“Presenter was very knowledgeable about the research and explained research concepts well.”
“Sandeep did a great job presenting. I appreciated his clarity.”
“I learned how psychedelics show promise for treatment of depression and substance use and the importance of context in delivery of treatment. ”
|
“I appreciated the commentary on efficacy/non efficacy of psychedelics when mixed with certain types of Psychotropic medications. ”
For more information contact: [email protected]
The Ross Center is approved by the American Psychological Association to sponsor continuing education for psychologists. The Ross Center maintains responsibility for this program and its content.
The Ross Center for Anxiety and Related Disorders LLC is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0105.
Ross Management Services, LLC is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0701
There is no conflict of interest or commercial support for this program.
